STOCK TITAN
  1. Home
  2. Sec-filings
  3. NRBO
  4. [EFFECT] NeuroBo Pharmaceuticals, Inc. Common Stock SEC Filing

[EFFECT] NeuroBo Pharmaceuticals, Inc. Common Stock SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 10, 2025 5:00 P.M.
Form: S-3
CIK: 0001638287
Company Name: MetaVia Inc.
File Number: 333-288486

Source: View Original Filing on SEC EDGAR

Stock NRBO logo
Neurobo Pharmaceuticals Inc

NASDAQ:NRBO

NRBO Rankings

#8739 Ranked by Market Cap
N/A Ranked by Dividends

NRBO Latest News

Nov 18, 2024
NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases
Nov 13, 2024
NeuroBo Pharmaceuticals to Participate in Investor Conferences in November
Nov 7, 2024
NeuroBo Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Nov 4, 2024
NeuroBo Pharmaceuticals Completes Last Patient Last Visit in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
Oct 1, 2024
NeuroBo Pharmaceuticals to Participate in Investor Conferences in October

NRBO Latest SEC Filings

Jul 10, 2025
[424B3] NeuroBo Pharmaceuticals, Inc. Common Stock Prospectus Filed Pursuant to Rule 424(b)(3)
Jul 9, 2025
[8-K] NeuroBo Pharmaceuticals, Inc. Common Stock Reports Material Event
Jul 2, 2025
[S-3] NeuroBo Pharmaceuticals, Inc. Common Stock Shelf Registration Statement
Jul 1, 2025
[Form 4] NeuroBo Pharmaceuticals, Inc. Common Stock Insider Trading Activity
Jul 1, 2025
[Form 4] NeuroBo Pharmaceuticals, Inc. Common Stock Insider Trading Activity

NRBO Stock Data

20.33M
3.00M
65.24%
12.71%
0.4%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE